Abstract
No woman is at greater risk for ovarian carcinoma than one who is a member of a hereditary ovarian carcinoma syndrome kindred and whose mother, sister, or daughter has been affected with this disease and with an integrally related hereditary syndrome cancer. This article surveys the existing understanding about hereditary ovarian carcinoma. Emphasis is given to its diagnosis, heterogeneity, interpretation, and the application of this information to improving cancer control.
| Original language | English |
|---|---|
| Pages (from-to) | 783-811 |
| Number of pages | 29 |
| Journal | Hematology/Oncology Clinics of North America |
| Volume | 6 |
| Issue number | 4 |
| State | Published - 1992 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
Cite this
Hereditary ovarian carcinoma. / Lynch, Henry T.; Lynch, J. F.
In: Hematology/Oncology Clinics of North America, Vol. 6, No. 4, 1992, p. 783-811.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hereditary ovarian carcinoma
AU - Lynch, Henry T.
AU - Lynch, J. F.
PY - 1992
Y1 - 1992
N2 - No woman is at greater risk for ovarian carcinoma than one who is a member of a hereditary ovarian carcinoma syndrome kindred and whose mother, sister, or daughter has been affected with this disease and with an integrally related hereditary syndrome cancer. This article surveys the existing understanding about hereditary ovarian carcinoma. Emphasis is given to its diagnosis, heterogeneity, interpretation, and the application of this information to improving cancer control.
AB - No woman is at greater risk for ovarian carcinoma than one who is a member of a hereditary ovarian carcinoma syndrome kindred and whose mother, sister, or daughter has been affected with this disease and with an integrally related hereditary syndrome cancer. This article surveys the existing understanding about hereditary ovarian carcinoma. Emphasis is given to its diagnosis, heterogeneity, interpretation, and the application of this information to improving cancer control.
UR - http://www.scopus.com/inward/record.url?scp=0026684337&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026684337&partnerID=8YFLogxK
M3 - Article
C2 - 1500386
AN - SCOPUS:0026684337
VL - 6
SP - 783
EP - 811
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
SN - 0889-8588
IS - 4
ER -